US Patent Issued to QILU Pharmaceutical on March 4 for "Composition comprising aflibercept and a variant thereof, and related methods and uses" (Chinese Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,240,888, issued on March 4, was assigned to QILU Pharmaceutical Co. Ltd. (Shandong, China).

"Composition comprising aflibercept and a variant thereof, and related methods and uses" was invented by Yue Yu (Shandong, China), Guijiang Wang (Shandong, China), Jiulin Wang (Shandong, China), Zhenming An (Shandong, China), Qingmin Wang (Shandong, China), Daoyuan Li (Shandong, China), Chuanlei Liu (Shandong, China), Feifei Liu (Shandong, China), Huanlan Zheng (Shandong, China), Peng Wan (Shandong, China) and Bo Xie (Shandong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a composition comprising aflibercept and a variant thereof, wherein the ...